ESR1 and breast carcinoma: To further investigate the role of CNPY3 in breast cancer progression and metastasis, we next silenced CNPY3 in human breast cancer cell lines MCF-7 (ER+PR+BC) and MDA-MB-231 (TNBC) using a CRISPR/Cas9 lentiviral system.